MedTrace Logo

Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

NCT05432505 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-06-27

No results posted yet for this study

Summary

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.

Conditions

  • Orthopedic Disorder

Interventions

OTHER

ligamentum teres tenodesis

Identification of ligamentum teres ligamentum teres tenodesis

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Eligibility

Min Age
9 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2023-01-31
Completion
2023-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432505 on ClinicalTrials.gov